测定绿脓菌素和布拉酵母菌对大鼠盲肠结扎穿刺诱导的脓毒症中肠道微生物群以及TLR4/MyD88/NF-κB和NLRP3信号通路的影响。

Determination of the effect of pyocyanin and Saccharomyces boulardii on gut microbiota and TLR4/MyD88/NF-κB and NLRP3 signaling pathways in sepsis induced by cecal ligation and puncture in rats.

作者信息

Ucar Mahmut, Celebi Ozgur, Celebi Demet, Baser Sumeyye, Guler Mustafa Can, Tanyeli Ayhan, Kılıclıoglu Metin, Yılmaz Ahmet, Yıldırım Serkan

机构信息

Department of Medical Microbiology, Atatürk University, Faculty of Medicine, Erzurum, 25240, Turkey.

Department of Microbiology, Atatürk University, Faculty of Veterinary, Erzurum, 25240, Turkey.

出版信息

BMC Infect Dis. 2025 Jul 21;25(1):931. doi: 10.1186/s12879-025-11308-4.

Abstract

Sepsis is a life-threatening systemic inflammatory condition marked by a dysregulated host response to infection. The intestinal microbiota plays a pivotal role in maintaining immune homeostasis and epithelial barrier integrity, whereas dysbiosis significantly contributes to the pathogenesis of sepsis. This study investigates the effects of the Pseudomonas aeruginosa-derived metabolite Pyocyanin and the probiotic Saccharomyces boulardii (S. boulardii) on microbial composition and the TLR4/MyD88/NF-κB/NLRP3 signaling axis in a cecal ligation and puncture (CLP)-induced rat model of sepsis. The experimental design assessed the synergistic or antagonistic effects of single and combined treatments using molecular, microbiome, and immunohistochemical parameters to evaluate histopathological damage and microbial ecological dynamics. Seven experimental groups were established following CLP. Intra-abdominal Pyocyanin (10 nmol/g) and oral probiotic (10⁶ CFU/kg) treatments were administered either individually or in combination. Focused Ion Beam - Scanning Electron Microscopy (FIB-SEM) analyses revealed that the amorphous structure of Pyocyanin interacted with the surface of S. boulardii. Western blot analysis showed a 2.3-fold increase in TLR4/NF-κB expression in the CLP group (p ≤ 0.05), which synergistically rose to 4.5-fold with Pyocyanin (p ≤ 0.001), whereas probiotic treatment decreased expression levels by 35%. According to 16 S rRNA sequencing, Pyocyanin reduced α-diversity by increasing Lactobacillaceae abundance to 32.66% (Shannon index: 3.598 vs. 4.433 in control), while S. boulardii enhanced β-diversity by elevating Coriobacteriaceae (5.85%) and Prevotellaceae (10.63%) levels (Tables 2, 3 and 4). PCoA confirmed 41.7% Bray-Curtis dissimilarity between groups at the species level (PERMANOVA R²=0.38, p = 0.002). Histopathologically, severe hepatocyte necrosis (73.2 ± 6.1%, p = 0.0022) and a 4.2-fold increase in hepatic TGF-β expression were observed in the CLP group, whereas epithelial barrier damage was significantly attenuated in the probiotic groups. Immunofluorescence analysis revealed that combined treatment reduced Caspase-8 and TLR4 expression by 28% compared to Pyocyanin alone (p ≤ 0.05). In conclusion, S. boulardii supported microbiota homeostasis by suppressing TLR4/NF-κB signaling, whereas Pyocyanin exacerbated the inflammatory response via NLRP3 activation. These findings provide molecular evidence supporting probiotic-assisted immunomodulatory strategies in sepsis therapy.

摘要

脓毒症是一种危及生命的全身性炎症状态,其特征为宿主对感染的反应失调。肠道微生物群在维持免疫稳态和上皮屏障完整性方面起着关键作用,而微生物群失调则在很大程度上导致了脓毒症的发病机制。本研究在盲肠结扎穿刺(CLP)诱导的大鼠脓毒症模型中,研究了铜绿假单胞菌衍生代谢产物绿脓杆菌素和益生菌布拉氏酵母菌(S. boulardii)对微生物组成以及TLR4/MyD88/NF-κB/NLRP3信号轴的影响。实验设计通过分子、微生物组和免疫组化参数评估单一治疗和联合治疗的协同或拮抗作用,以评估组织病理学损伤和微生物生态动态。CLP后建立了七个实验组。腹腔内给予绿脓杆菌素(10 nmol/g)和口服益生菌(10⁶ CFU/kg),可单独给药或联合给药。聚焦离子束扫描电子显微镜(FIB-SEM)分析显示,绿脓杆菌素的无定形结构与布拉氏酵母菌表面相互作用。蛋白质印迹分析表明,CLP组中TLR4/NF-κB表达增加了2.3倍(p≤0.05),与绿脓杆菌素联合使用时协同增加至4.5倍(p≤0.001),而益生菌治疗使表达水平降低了35%。根据16S rRNA测序,绿脓杆菌素通过将乳酸杆菌科丰度增加到32.66%降低了α-多样性(香农指数:对照组为4.433,处理组为3.598),而布拉氏酵母菌通过提高棒状杆菌科(5.85%)和普雷沃氏菌科(10.63%)水平增强了β-多样性(表2、3和4)。主坐标分析(PCoA)证实,在物种水平上,各组之间的布雷-柯蒂斯差异为41.7%(PERMANOVA R²=0.38,p=0.002)。组织病理学上,CLP组观察到严重的肝细胞坏死(73.2±6.1%,p=0.0022),肝脏TGF-β表达增加了4.2倍,而益生菌组上皮屏障损伤明显减轻。免疫荧光分析显示,与单独使用绿脓杆菌素相比,联合治疗使Caspase-8和TLR4表达降低了28%(p≤0.05)。总之,布拉氏酵母菌通过抑制TLR4/NF-κB信号传导来维持微生物群稳态,而绿脓杆菌素则通过激活NLRP3加剧炎症反应。这些发现为脓毒症治疗中益生菌辅助免疫调节策略提供了分子证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索